Predicate Research Report · generated 2026-08-21 · Print / save as PDF · Save to account
KLN — Predicate Candidate Screening
14 FDA 510(k) clearances under this product code; the 50 most recent screened below.
37 daysmedian FDA review time
228 days90th percentile
14clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K010868 | PSYCHEMEDICS RIA COCAINE ASSAY | Psychemedics Corp. | 2001-11-06 | 228 | 0 |
| K913867 | URINE COCAINE METABOLITE DIRECT RIA KIT (I-125) | Immunalysis Corporation | 1991-09-19 | 23 | 0 |
| K913722 | ABUSCREEN(R) RADIOIMMUN FOR COCAINE METABOLITE | Roche Diagnostic Systems, Inc. | 1991-09-10 | 25 | 0 |
| K912756 | ABUSCREEN RADIOIMMUNOASSAY FOR COCAINE METABOLITE | Roche Diagnostic Systems, Inc. | 1991-07-26 | 35 | 0 |
| K910122 | TARGET COCAINE METABOLITE-R | V-Tech, Inc. | 1991-03-19 | 67 | 0 |
| K910123 | TARGET COCAINE METABOLITE-V | V-Tech, Inc. | 1991-03-19 | 67 | 0 |
| K910044 | MILENIA COCAINE METABOLITE | Diagnostic Products Corp. | 1991-02-13 | 40 | 0 |
| K905730 | ABUSCREEN ONTRAK FOR COCAINE (200NG/ML) | Roche Diagnostic Systems, Inc. | 1991-01-15 | 22 | 0 |
| K904995 | ABUSCREEN ONLINE TM FOR COCAINE METABOLITE | Roche Diagnostic Systems, Inc. | 1990-11-28 | 21 | 0 |
| K880674 | MICROMEDIC CRACKPOT RIA KIT | Icn Micromedic Systems | 1988-10-06 | 230 | 0 |
| K871549 | RESUB. URINE COCAINE META. DIRECT RIA KIT [I-125] | Immunalysis Corporation | 1987-06-16 | 63 | 0 |
| K870740 | COAT-A-COUNT COCAINE METABOLITE TKCN1 & TKCN5 | Diagnostic Products Corp. | 1987-03-19 | 22 | 0 |
| K862218 | DOUBLE ANTIBODY COCAINE METABOLITE RIA KIT | Diagnostic Products Corp. | 1986-06-27 | 16 | 0 |
| K830480 | ABUSCREEN RADIOIMMUNOASSAY-COCAINE META | Hoffmann-La Roche, Inc. | 1983-03-24 | 37 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda